Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Tumori|June 11, 2013
One-day DCF regimen in patients with metastatic gastric cancerAhmet Dirican, Yuksel Kucukzeybek, Mustafa Oktay Tarhan, et al.
Chemotherapy|April 13, 2016
Prognostic Value of the Pretreatment Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio for Patients with Neuroendocrine Tumors: An Izmir Oncology Group StudyTarik Salman, Seher Nazli Kazaz, Umut Varol, et al.
European Geriatric Medicine|March 12, 2022
The relationship between sarcopenia detected in newly diagnosed colorectal cancer patients and FGF21, irisin and CRP levelsUtku Oflazoglu, Sevinc Caglar, Huriye Erbak Yılmaz, et al.
The Breast Journal|March 29, 2014
Prognostic evaluation of breast cancer patients with evident bone marrow metastasisLutfiye Demir, Murat Akyol, Sadi Bener, et al.
Case Reports in Oncological Medicine|July 15, 2014
Isolated liver metastasis of sacrococcygeal chordoma: case report and review of the literatureMurat Akyol, Umut Varol, Ibrahim Yildiz, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|May 18, 2013
Prognostic and predictive value of hematologic parameters in patients with metastatic renal cell carcinoma: second line sunitinib treatment following IFN-alphaAhmet Dirican, Yuksel Kucukzeybek, Cigdem Erten, et al.
Clinical & Experimental Metastasis|July 10, 2013
Predictive and prognostic factors in locally advanced breast cancer: effect of intratumoral FOXP3+ TregsLutfiye Demir, Seyran Yigit, Hulya Ellidokuz, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|September 18, 2014
Second-line capecitabine and oxaliplatin combination for gemcitabine-resistant advanced pancreatic cancerIbrahim Vedat Bayoglu, Umut Varol, Ibrahim Yildiz, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|July 8, 2014
Treatment of metastatic colorectal cancer with or without bevacizumab: can the neutrophil/lymphocyte ratio predict the efficiency of bevacizumab?Ahmet Dirican, Umut Varol, Yuksel Kucukzeybek, et al.
Cancer Biomarkers : Section a of Disease Markers|June 6, 2013
The effects of hematological parameters and tumor-infiltrating lymphocytes on prognosis in patients with gastric cancerAhmet Dirican, Nese Ekinci, Arzu Avci, et al.
Pageof 6